1 Unstoppable Growth Stock to Buy in 2023 and Beyond
The Motley Fool
OCTOBER 20, 2023
TransMedics held its initial public offering (IPO) in 2019 and saw its stock rise over 300% by 2023. Despite this blistering growth, the company's net profit margin has rapidly improved each quarter as well, nearly reaching breakeven in the second quarter of 2023. TMDX Revenue (Quarterly) data by YCharts.
Let's personalize your content